1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Turkey Pharmaceuticals and Healthcare Report Q3 2016

Turkey Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 87 pages

Includes 3 FREE quarterly updates

BMI View: Turley will remain one of the largest markets in Central and Eastern Europe for bothhealthcare expenditure and pharmaceutical sales, boosted by a growing and ageing population with a highprevalence of non-communicable diseases. A poor regulatory environment, intellectual property protectionissues and continued geopolitical risks with its neighbours will weigh down on growth potential.

Headline Expenditure Projections

- Pharmaceuticals: TRY20.81bn (USD7.64bn) in 2015 to TRY22.82bn (USD7.71bn) in 2016; +9.7% inlocal currency and 0.9% US dollar terms. Forecast unchanged in local currency and up in US dollarscompared with previous quarter due to revised exchange rate expectations.

- Healthcare: TRY106.88bn (USD39.24bn) in 2015 to TRY119.68bn (USD40.43bn) in 2016; 12.0% inlocal currency and 3.0% US dollar terms. Forecast revised up due to latest data and revised exchangerate expectations.

Table Of Contents

Turkey Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Turkey 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Turkey 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Turkey 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Turkey 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Turkey 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Turkey 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Turkey 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Turkey 2014-2020) 29
Industry Risk/Reward Index 30
Central And Eastern Europe Risk/Reward Index - Q3 2016 30
Turkey Risk/Reward Index 36
Rewards 36
Risks 37
Regulatory Review 38
Intellectual Property Issues 38
Pricing Regime 41
Reimbursement Regime 42
Market Overview 43
Healthcare Sector 44
Table: Healthcare Resources (Turkey 2010-2015) 47
Table: Healthcare Personnel (Turkey 2010-2015) 47
Table: Healthcare Activity (Turkey 2010-2015) 48
Research and Development 48
Clinical Trials 49
Epidemiology 50
Competitive Landscape 53
Pharmaceutical Sector 53
Research-Based Industry 54
Generic Drugmakers 55
Table: Multinational Market Activity 57
Pharmaceutical Distribution 58
Pharmaceutical Retail 59
Company Profile 60
Abdi ?brahim 60
EastPharma (Deva) 64
Eczaciba?i Healthcare 67
Mustafa Nevzat Ilac Sanayi (MN) Pharmaceuticals 70
Sanovel Pharmaceuticals 73
Demographic Forecast 76
Table: Population Headline Indicators (Turkey 1990-2025) 77
Table: Key Population Ratios (Turkey 1990-2025) 77
Table: Urban/Rural Population and Life Expectancy (Turkey 1990-2025) 78
Table: Population By Age Group (Turkey 1990-2025) 78
Table: Population By Age Group % (Turkey 1990-2025) 79
Glossary 81
Methodology 83
Pharmaceutical Expenditure Forecast Model 83
Healthcare Expenditure Forecast Model 83
Notes On Methodology 84
Risk/Reward Index Methodology 85
Index Overview 86
Table: Pharmaceutical Risk/Reward Index Indicators 86
Indicator Weightings 87

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.